THE GENETIC, CELLULAR AND MOLECULAR BASIS OF IDIOSYNCRATIC DRUG TOXICITY
- In: B1 - “Getting personal”: pharmacogenomics at the crossroads of practice and science on Thursday, 1 October 2015, 09:00-12:00
- At: Düsseldorf (Germany) (2015)
- Type: Presentation
- By: PARK, Kevin (University of Liverpool, Institute of Translational Medicine, Liverpool, United Kingdom)
- Co-author(s): Kevin Park
Adverse drug reactions (ADRs) remain a major problem in the clinic and in drug development, of particular concern are those ADRs of an idiosyncratic nature. Such reactions are still poorly understood, but nevertheless often assumed to be immunological in nature. Recent advances in pharmacogenetics, most notably HLA restriction, have provided the.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.